|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/20 | |
| A61K 47/48 |
| (11) | Number of the document | 2066336 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07867161.7 |
| Date of filing the European patent application | 2007-09-27 | |
| (97) | Date of publication of the European application | 2009-06-10 |
| (45) | Date of publication and mention of the grant of the patent | 2012-09-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2007/020871 |
| Date | 2007-09-27 |
| (87) | Number | WO 2008/054585 |
| Date | 2008-05-08 |
| (30) | Number | Date | Country code |
| 848326 P | 2006-09-28 | US | |
| 915603 P | 2007-05-02 | US |
| (72) |
OFT, Martin, US
SHEPPARD, Catherine, US
MUMM, John, US
LINGLING, Wu, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | USE OF PEGYLATED IL-10 TO TREAT CANCER |
| USE OF PEGYLATED IL-10 TO TREAT CANCER |